Parathyroid hormone-related protein in pancreatic exocrine cancer associated with hypercalcaemia

International Journal of Clinical Practice

Volumn 57, Issue 2, 2003, Pages 140-142

  Bandyopadhyay, Prabirkumar ^a   Baksi, S ^a   Bandyopadhyay, D ^a   Patel, C U ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CALCITONIN; DEXAMETHASONE; FUROSEMIDE; PAMIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN;

ADULT; ADVANCED CANCER; ARTICLE; BONE METASTASIS; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; EXOCRINE GLAND; HUMAN; HYPERCALCEMIA; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; PANCREAS CANCER; PRIORITY JOURNAL;

FATAL OUTCOME; HUMANS; HYPERCALCEMIA; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PARATHYROID HORMONE-RELATED PROTEIN; PEPTIDE FRAGMENTS; PROTEINS;

EID: 0037344769     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Mason RS. Clinching the diagnosis: an approach to the investigation of hypercalcaemia. Pathology 1986; 18: 243-248.
2. Walls J, Ratcliffe WA, Howell A et al. Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations. Clin Endocrinol 1994; 41: 407-413.
3. Bilezikian JP. Etiologies and therapy of hypercalcaemia. Endocrinol Metab Clin North Am 1989; 18: 389-414.
4. Nagata N. Malignant tumour and hypercalcaemia. LOH. Clin Calcium 1992; 2: 660-667 (in Japanese).
5. Kakizaki S, Ohya N, Yoshinaga T et al. Undifferentiated pancreatic cancer associated with humoral hypercalcemia of malignancy. Jpn J Clin Oncol 1998; 28(9): 563-566.
6. Nagata N, Kugai N, Maemura M et al. Enhancement of cyclic adenosine monophosphate content in bone cells by the factor extracted from a pancreatic cancer associated with hypercalcemia. Metabolism 1986; 35: 529-534.
7. Birkeland KI, Gallefoss F, Olsson S, Haug E. Primary hyperparathyroidism or hypercalcaemia of malignancy? Scand J Clin Lab Invest 1992; 52: 347-349.
8. Miraliakbari BA, Asa SL, Boudreau SF. Parathyroid hormone-like peptide in pancreatic endocrine carcinoma and adenocarcinoma associated with hypercalcaemia. Hum Pathol 1992; 23: 884-887.
9. Tachibana I, Nakano S, Akiyama T et al. Parathyroid hormone related protein mediates hypercalcemia in an exocrine pancreatic cancer. Am J Gastroenterol 1994; 89: 1580-1581.
10. Yamamoto M, Nakano S, Mugikura M et al. Pancreatic cancer and hypercalcemia associated with von Recklinghausen's disease. J Gastroenterol 1996; 31: 728-731.
11. Ries LAG, Hankey BF, Miller BA et al. Cancer statistics review 1973-1988. Bethesda, MD: National Cancer Institute, 1991.
12. Ratcliffe WA, Norbury S, Heath DA, Ratcliffe JG. Development and validation of an immunoradiometric assay for parathyrin-related protein in unextracted plasma. Clin Chem 1991; 37: 678-685.
13. Heath DA, Senior PV, Varley JM, Beck F. Parathyroid hormone related protein in tumours associated with hypercalcaemia. Lancet 1990; 335: 66-69.
14. Burtis WJ, Brady TG, Orloff JJ et al. Immunochemical characterisation of circulating parathyroid-hormone related protein in patients with humoral hypercalcemia of cancer. N Engl J Med 1990; 322: 1106-1112.
15. Philbrick WM, Wysolmerski JJ, Galbraith S et al. Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev 1996; 76: 127-173.
16. Martin TJ, Mosely JM, Williams ED. Parathyroid hormone-related protein: hormone and cytokine. J Endocrinol 1997; 154: 523-537.
17. Fraser WD, Robinson J, Lawton R et al. Clinical and laboratory studies of a new immunoradiometric assay of parathyroid hormone-related protein. Clin Chem 1993; 39: 414-419.
18. Ralston SH, Danks J, Hayman J et al. Parathyroid hormone-related rotein of malignancy: immunohistochemical and biochemical studies in normocalcemic and hypercalcemic patients with cancer. J Clin Pathol 1991; 44: 472-476.
19. Mangin M, Ikeda K, Dreyer BE, Broadus AE. Isolation and characterization of the human parathyroid hormone-like peptide gene. Proc Natl Acad Sci USA 1989; 86: 2408-2412.
20. Mangin M, Webb AC, Dreyer BE et al. Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy. Proc Natl Acad Sci USA 1988; 85: 597-601.
21. Blind E, Raue F, Götzmann J et al. Circulating levels of midregional parathyroid hormone-related protein in hypercalcemia of malignancy. Clin Endocrinol 1992; 37: 290-297.
22. Ratcliffe WA, Hutchesson ACJ, Bundred NJ, Ratcliffe JG. Role of assays for parathyroid hormone-related protein in investigation of hypercalcaemia. Lancet 1992; 339: 164-167.
23. Yoneda T, Nakai M, Moriyama K et al. Neutralising antibodies to human interleukin 6 reverse hypercalcemia associated with a human squamous carcinoma. Cancer Res 1993; 53: 737-740.
24. Yoneda T, Alsina MA, Chavez JB et al. Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia and leucocytosis in a human tumor in nude mice. J Clin Invest 1991; 87: 977-985.
25. Sato K, Fujii K, Kasono K et al. Parathyroid hormone related protein and interleukin-1a synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in vivo. Endocrinology 1989; 124: 2172-2178.
26. Nagata N, Akatsu T, Kugai N et al. The tumor cells (FA-6) established from a pancreatic cancer associated with humoral hypercalcemia of malignancy: a simultaneous production of parathyroid hormone-like activity and transforming growth factor activity. Endocrinol Japon 1989; 36(1): 75-85.
27. Carano A, Teitelbaum SL, Konsek JD et al. Biphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest 1990; 85: 456-461.